Evaluation of the pacific biotech CARDS STREP A test for detecting group A streptococci from cases of pharyngitis.
AUTOR(ES)
Manasse, R J
RESUMO
The Pacific Biotech CARD STREP A test for rapid screening of throat specimens for group A streptococci was evaluated. Relative to conventional culture, this assay had a sensitivity of 76.1% (108 of 142) and a specificity of 98.7% (392 of 397). The relatively low sensitivity of the test makes it of questionable value as a screening procedure.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=267634Documentos Relacionados
- Evaluation of the Directigen 1,2,3 Group A Strep Test for diagnosis of streptococcal pharyngitis.
- Evaluation of two rapid antigen assays, BioStar Strep A OIA and Pacific Biotech CARDS O.S., and culture for detection of group A streptococci in throat swabs.
- Evaluation of two rapid antigen assays, BioStar Strep A OIA and Pacific Biotech CARDS O.S., and culture for detection of group A streptococci in throat swabs.
- Group B beta-hemolytic streptococci causing pharyngitis.
- M proteins of group C streptococci isolated from patients with acute pharyngitis.
